ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 198.50
-0.50 (-0.25%)
Sep 18, 2026, 4:59 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 44.04 billion as of September 18, 2026. Its market cap has decreased by -4.45% in one year.
Market Cap
44.04B
Enterprise Value
42.73B
Revenue
6.83B
Ranking
n/a
PE Ratio
32.55
Stock Price
198.50
ChartMarket Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 44.04B, an increase of 537.56%. That is a compound annual growth rate of 9.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 44.04B | -12.90% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.25T |
| Genmab | 134.09B |
| Coloplast | 94.37B |
| Demant | 63.48B |
| H. Lundbeck | 41.63B |
| Zealand Pharma | 19.27B |
| Ambu A/S | 17.10B |
| Bavarian Nordic | 15.70B |